?

Lone's Cempanies, Ine. Consolidated Balance Sthets (It mitlicen, excepl pat value) Janwary 28,2022 January 29,2021 Liabilities and shareholders' (deficitliequity Current liabilities: Commitments and contingevctes Shareholders' (deficit) equity: Preferred stock -55 par value; Auhorised -5.0 million sharts: Issued and outstanding - nose Cortmoa stock - $0.50 par value Autharized - 5,6 bilion shares; Issued and outstanding -670 million and 731 million, respectively Capital in exeess of par value (Accurmulafed deficit) retained camings Accumalated other cemprehensive loss Total shareholders' (deficit)/equity Total Labidities and shareholders" (deficievequity Set accompanying nores to consolidard financiat stancments. 39 Lowe's Companies, Inc. Consolidated Statemeats of Earnings (tn millions, execpt per share and percentage data Lowe's Companies, Inc. Consolidated Statements of Comprehensive Income (In millions, except percentage data) Dowe's Companies, Inc. Consolidated Statemeats of Shareholderst (Deficit) Fquiry Efficiency Indicators Aecoumts Recervable numover Rinte Net Sivet Arsage Anocults Recherimbin not Des =sin int 10 an 2025 2935 Mumber of Aoys' Salet in Aesolvabios twerem me Deysna Yerr (205) Namint Receviobe Fusover Rate Imventory Tumnover Rasio Number of Dsys' Sales in inveatory \( \frac{\text { Dags in a Year (Pes) }}{\hline \text { inventoy Tumover Roso }} \) (N) In Aet cos in ant 365 siomex trowex nanmanmanman 000 Accounts Payable Tumover Ratio Number of Deys" Purchases in Accounts Payable Days in a Year (365) Accouns Parable Tumover Rato Cash-to-Cash Cycle Nermber of Dapes Sales in iovertioy Ner Namber of Dess Cash is hwesied in iveveray plus Number at Dayr Stres in Rpoovabios Cash to-Cash Days =sin0,24 tes nidert ire xre sen 647 trexer sin 400 Fired Asset Tumover Rado 2021 2020 Inaxom Bug. YeA End in Ant Aurage Imas 4.73 Lone's Cempanies, Ine. Consolidated Balance Sthets (It mitlicen, excepl pat value) Janwary 28,2022 January 29,2021 Liabilities and shareholders' (deficitliequity Current liabilities: Commitments and contingevctes Shareholders' (deficit) equity: Preferred stock -55 par value; Auhorised -5.0 million sharts: Issued and outstanding - nose Cortmoa stock - $0.50 par value Autharized - 5,6 bilion shares; Issued and outstanding -670 million and 731 million, respectively Capital in exeess of par value (Accurmulafed deficit) retained camings Accumalated other cemprehensive loss Total shareholders' (deficit)/equity Total Labidities and shareholders" (deficievequity Set accompanying nores to consolidard financiat stancments. 39 Lowe's Companies, Inc. Consolidated Statemeats of Earnings (tn millions, execpt per share and percentage data Lowe's Companies, Inc. Consolidated Statements of Comprehensive Income (In millions, except percentage data) Dowe's Companies, Inc. Consolidated Statemeats of Shareholderst (Deficit) Fquiry Efficiency Indicators Aecoumts Recervable numover Rinte Net Sivet Arsage Anocults Recherimbin not Des =sin int 10 an 2025 2935 Mumber of Aoys' Salet in Aesolvabios twerem me Deysna Yerr (205) Namint Receviobe Fusover Rate Imventory Tumnover Rasio Number of Dsys' Sales in inveatory \( \frac{\text { Dags in a Year (Pes) }}{\hline \text { inventoy Tumover Roso }} \) (N) In Aet cos in ant 365 siomex trowex nanmanmanman 000 Accounts Payable Tumover Ratio Number of Deys" Purchases in Accounts Payable Days in a Year (365) Accouns Parable Tumover Rato Cash-to-Cash Cycle Nermber of Dapes Sales in iovertioy Ner Namber of Dess Cash is hwesied in iveveray plus Number at Dayr Stres in Rpoovabios Cash to-Cash Days =sin0,24 tes nidert ire xre sen 647 trexer sin 400 Fired Asset Tumover Rado 2021 2020 Inaxom Bug. YeA End in Ant Aurage Imas 4.73